Flagship explainer

How Nuo Therapeutics, Inc. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$3.3M · 100%Cost of revenue$1.1M · 33%Gross profit$2.2M · 67%Operating income−$2.5M · −76%Income before tax−$2.5M · −76%Income tax$0 · 0%Net income−$2.5M · −76%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$3.3M100%
Cost of revenue$1.1M33%
$2.2M67%
−$2.5M−76%
Income before tax−$2.5M−76%
Income tax$00%
−$2.5M−76%
Source: · event Dec 31, 2025 · retrieved Oct 16, 2026 · annual-row source set
Embed this chart

View the full Nuo Therapeutics, Inc. analysis at Buy Like Buffett